Needham & Company Cuts Price Target on Imperva (IMPV) Following 3Q

Go back to Needham & Company Cuts Price Target on Imperva (IMPV) Following 3Q

DA Davidson Upgrades Imperva (IMPV) to Buy

November 4, 2016 7:14 AM EDT

DA Davidson upgraded Imperva (NYSE: IMPV) from Neutral to Buy.

For an analyst ratings summary and ratings history on Imperva click here. For more ratings news on Imperva click here.

Shares of Imperva closed at $35.10 yesterday.

... More

Evercore ISI Upgrades Imperva (IMPV) to Buy

November 4, 2016 7:13 AM EDT

Evercore ISI upgraded Imperva (NYSE: IMPV) from Hold to Buy.

For an analyst ratings summary and ratings history on Imperva click here. For more ratings news on Imperva click here.

Shares of Imperva closed at $35.10 yesterday.

... More

Imperva (IMPV) Tops Q3 EPS by 24c, Plans to Remain Standalone Compnay

November 3, 2016 4:44 PM EDT

Imperva (NYSE: IMPV) reported Q3 EPS of $0.08, $0.24 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $68.4 million versus the consensus estimate of $63.1 million.

GUIDANCE:

Imperva sees FY2016 EPS of ($0.38)-($0.35), versus the consensus of ($0.80). Imperva sees FY2016 revenue of $255.1-257.1 million, versus the consensus of $250.2 million.

Conclusion of Strategic Alternatives Review Process

Imperva announced today that its Board of Directors has concluded its previously announced review of strategic alternatives to enhance... More

Trading Radar for 11/3: GoPro (GPRO), Chesapeake (CHK), Activision (ATVI), Fossil (FOSL), Starbucks (SBUX) Report

November 2, 2016 2:08 PM EDT

The Trading Radar highlights key earnings and economic announcements for the next trading session:

Before Markets Open:
Economics:
8:30am EDT

Initial Claims - Street sees 256kContinuing Claims - no Street consensusUnit Labor Costs - Street sees 1.2%Productivity: Prelim. - Street sees 1.8%

Earnings:

3D Systems (NYSE: DDD) - consensus EPS $0.09
AAC Holdings (NYSE: AAC) - no Street consensus
ACI Worldwide, Inc. (Nasdaq: ACIW) - consensus EPS $0.14
AMAG Pharma... More